Fut, nem toborozFázis nélkül
International Post Market Surveillance Study of Intracranial Aneurysms Treated With an Endovascular Approach
A legfontosabb adatok
- Ki végzi
- Stryker Neurovascular
- Hol
- Ausztria, Egyesült Királyság, Finnország, Franciaország, Németország, Olaszország és Svájc32 helyszín, 7 országbanVálassz országot a helyszínekhez
- Azonosító
- Állapot
- Fut, nem toboroz
- Résztvevők
- 405 fő vett részt
- Kezdés
- 2020. dec. 21.
- Befejezés
- 2025. aug.
- A vizsgálat típusa
- Megfigyeléses, 2 csoport
- A vizsgált kezelések
- Endovascular treatment of intracranial aneurysms using a flow-diverting stent
- A regiszteradat frissítve
- 2025. augusztus 7.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Nők és férfiak
- Egészséges önkéntesek
- Nem vehetnek részt
A regiszter feltételei, szó szerint
Mind a 22 feltétel megnézéseKevesebb
Ki vehet részt
- Subject has an intracranial aneurysm that can be treated with one of the proposed devices
- Subject age is ≥ 18 years
- Subject or subject's legally authorized representative (LAR) has signed written informed consent
- Subject is willing to comply with scheduled visits and examinations per institutional standard of care
Ki nem vehet részt
- Subject is currently enrolled in or plans to be enrolled in a concurrent drug or device study
- Subject has a non-target aneurysm treated within 30 days prior to study enrollment
- Subject target aneurysm is a ruptured intracranial aneurysm (unless ruptured at least 21 days prior the day of the index procedure)
- Antiplatelet and/or anticoagulation therapy (e.g., aspirin and clopidogrel) is contraindicated for the subject
- Intracranial vasospasm not responsive to medical therapy; Additional Key Exclusion Criteria (Evolve EU only):
- Subject has a non-target aneurysm treated within 30 days prior to study enrollment
- Subject has undergone previous stent assisted coiling or flow diverter treatment of a parent artery aneurysm near the location of the target aneurysm
- Subject has a condition which will not allow him/her to comply with his/her post-procedure follow up per the institutional standard of care (medical condition, subject living abroad and unable to return for follow-up, e.g.)
- Subject has an active bacterial or viral infection
- The angiography demonstrates the anatomy is not appropriate for endovascular treatment, due to conditions such as:
- Subject has not received dual anti-platelet agents prior to the procedure or equivalent in accordance with standard medical practice
- Subject is pregnant or plans to become pregnant her study participation*
- Subject has a planned treatment of a non-target aneurysm in the same vascular territory during participation in the study
- Subject has a target aneurysm other than saccular or fusiform intracranial aneurysms; e.g.: vertebrobasilar dolichoectasia (VBD)
- The parent vessel size does not fall within the indicated range defined by IFU
- Severe intracranial vessel tortuosity or stenosis; and/or
- Subject has a planned treatment of a non-target aneurysm in the same vascular territory during participation in the study
- Subject has a modified Rankin Score (mRS) ≥3 at pre-procedure examination
Ennek a vizsgálatnak nincs helyszíne itt: Egyesült Államok.
7 országban van helyszíne. Válassz országot, hogy lásd a helyszíneket.
A vizsgálatról
Mit akar kideríteni a vizsgálat
IMPACT is an observational, post market study designed to provide an ongoing safety and performance evaluation of Stryker Neurovascular devices used for the treatment of intracranial aneurysms with an endovascular approach.
A vizsgálat 2 csoportja
- Evolve EU
Selected hospitals for participation
Kezelés: Endovascular treatment of intracranial aneurysms using a flow-diverting stent
- Evolve FR
All hospitals in France using the device
Kezelés: Endovascular treatment of intracranial aneurysms using a flow-diverting stent
Adatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- IMPACT: International Post Market Product Surveillance Study of IntrACranial Aneurysms Treated With an Endovascular Approach
- A regiszteradat frissítve
- 2025. augusztus 7.